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ABSTRACT 
Memory CD8+ T cells are critical for long-term protection against intracellular 
pathogens and tumors. STING signals enable the transcription of pro-inflammatory 
molecules, such as type I IFNs, in response to nucleic acids from pathogens or self . 
Although the STING signaling pathway is best characterized for generating antiviral 
responses, recent evidence indicates STING signaling is involved in regulating IFN-
independent cellular responses in innate immune cells. However, it’s role in T cells is still 
poorly understood. Our collaborators published that enhanced STING signaling leads to 
a decrease in T cell protective immunity in a mechanism independent of direct IFN 
signaling on T cells. Our data indicates that CD8 T cells expand and clear infection but 
subsequently vanish without differentiating into memory. This is not due to impairments 
in memory programming, rather, CD8 T cell death is induced due to high levels of the 
apoptotic molecule Bim. Our data also suggest that T cell death via STING signaling could 
be attributed to its ability to modulate tryptophan metabolism. STING signaling can 
upregulate the enzyme IDO to catalyze the oxidation of tryptophan, a necessary amino 
acid for T cell survival. Indeed, IDO inhibition is able to return Bim expression to wildtype 
levels and restore the generation of memory T cells. Collectively, our data emphasizes a 
role for tryptophan metabolism in the generation of memory CD8 T cells and suggests 
enhancing STING signaling might not be beneficial in all T cell responses.  
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INTRODUCTION 
Generation of Immunological Memory is a hallmark of the Adaptive Immune 
System in response to infections, cancer, and autoimmunity. Mature memory CD8 T cell 
populations are established at the end of an immune response to intracellular pathogens 
such as Listeria monocytogenes or influenza. These memory CD8 T cells survive in the 
host for long periods of time and are ready to provide an immediate and powerful 
protection in case of reinfection (1).  
The ontogeny of memory CD8 T cells is still a matter of debate. Some reports 
support a differentiation model where upon antigen recognition naïve T cells transition to 
effector cells (T cells with effector function) and then, from effector to memory cells along 
the immune response. Others, though, support a signal strength differentiation model 
where memory precursors (MPECs) would originate first from naïve T cells under weak 
or short signal input to move into stem cell memory or central memory T cells (-TSCM and 
TCM respectively-) (2). Continuation of signal input or strong signals, would trigger further 
differentiation of these T cells into other effector-associated stages (effector memory T 
cells or TEM) and finally to terminal effector differentiation or death (short live effectors or 
SLECs) (3). It is very likely that both models coexist as memory T cell differentiation is a 
fairly plastic process and there is experimental evidence documenting generation of 
memory T cells very early and very late in the immune response (4).  Hence, T cell 
memory may be a default path that needs to be guaranteed under all conditions to 
maintain a memory population of the immunological insult. Furthermore, this might be of 
utmost advantage for the host as multiple ways to support memory development will 
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contribute to broaden the diversity of the T cell memory repertoire. This feature becomes 
more relevant as an individual ages and thymic output decreases (4).  
Regardless, all studies agree in the fact that for CD8 T cells, a transcriptional 
program is imprinted very early in the immune response (first 1-3 days) to control the 
molecular and biochemical steps necessary for a T cell to ultimately become a long-lived 
memory T cell or a short lived- dying effector. Differences in cytokine milieu and tissue 
environmental signals further contribute later in the response to shape the differentiation 
process and enable a wide array of T cell memory choices (resident memory, effector 
memory, central memory, circulating memory) (5). Eomes, TCF-1 and Bcl-6 are 
considered master transcription factors for T cell memory development, while T-bet and 
Blimp-1 favor the generation of terminal effector differentiation (6).  
The metabolism of T cells also changes along the differentiation process and 
impacts their terminal fate. At the peak of the response T cells that differentiate into 
effectors rely on glycolysis. Conversely, T cells that mature into memory need to abandon 
glycolysis and switch to fatty acid oxidation (FAO) and oxidative phosphorylation 
(OXPHOS) as metabolic sources of energy (7). Seemingly, amino acid sensing by 
differentiating T cells is also critical to meet the demands of protein synthesis and 
metabolic processes. Leucine, glutamine, arginine and serine are required for effector 
development (8). The role of tryptophan has remained elusive, perhaps because of its 
controversial role in immunity. Tryptophan processing by the enzyme indoleamine 2,3-
dioxygenase (IDO) produces kynoreunin metabolites that have immunomodulatory 
effects via Aryl hydrocarbon Receptor (AhR) signaling. However, depletion of tryptophan 
also restrains inflammation and promotes tolerance (9). Its role in CD8 memory 
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development still remains poorly understood. Intriguingly, agonists of AhR signaling 
impaired memory CD8 T cell development in an influenza model, which suggests that 
tryptophan metabolism might impact CD8 T cell differentiation (10). 
Ultimately, the “T cell memory decision” is a matter of life and death, or in 
other words, T cell survival. Hence, terminally differentiated effector T cells are doomed 
to die and even homeostatic cytokines fail to rescue them (11). By contrast, T cells that 
succeed to enter the memory pool possess the ability to survive and maintain a slow turn 
over. Interestingly, a great part of this process is determined very early in the response 
by the signals T cells encounter. Thus, upon antigen recognition, co-stimulatory and pro-
inflammatory signals set up naïve CD8 T cells to divide and die, or survive. Most of T cell 
expansion happens in the first 7 days of the immune response (12). By this time, naïve 
CD8 T cells have also acquired effector function, which contributes to the clearance of 
the pathogen. Once the pathogen is cleared, most T cells die and their numbers abruptly 
diminished in the contraction phase of the response. This is in part due to the signals 
naïve T cells integrate at the beginning of the response and in part due to the limited 
amount of pro-survival cytokines that are produced and can be consumed by the great 
number of expanded T cells (13). Cell death in the contraction phase is considered to be 
caspase independent and mainly driven by Bim and Puma, two pro-apoptotic proteins of 
the BH3-family that regulate survival versus cell death in the absence of cytokines (14, 
15). Strikingly, both drive T cell death during the contraction phase (16) in a way that 
cannot be compensated by overexpression of pro-survival factors Bcl-xL and Bcl-2 (17) 
or increased expression of pro-survival cytokines such as IL-7 (11). Thus, rather than 
being a matter of competition for survival cytokine signals, T cell death at contraction is 
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predetermined early in the response and programmed to occur later when cytokine levels 
are limited (18). Once CD8 T cells are selected to further mature into memory T cells, 
their IL-7 and IL-15 receptor levels increase. They become independent of T cell receptor 
(TCR) signaling and mainly rely on IL-7 and IL-15 signals to maintain survival and 
homeostasis (19).  
There are a number of signals at the beginning of the response that “mark” T 
cells to die or live. One of them is provided by pathogenic antigens which are associated 
to MHC molecules in the surface of antigen presenting cells (APCs) and recognized by 
the TCR (19-21). The other two signals are co-stimulation and pro-inflammatory 
cytokines, which are also delivered by APCs. Among the pro-inflammatory cytokines, type 
I interferons (IFNs) and IL-12 are crucial for the development of memory CD8 T cells (22). 
Several innate cells can secrete these cytokines in response to pathogen associated 
molecular patterns (PAMPs) from pathogens through different mechanisms. Toll-like 
receptors (TLRs) are specialized to interact with a wide array of pathogenic invariant 
ligands (from lipopolysaccharides and endotoxins to peptidoglycans and nucleic acids 
and others). In the case of intracellular pathogens, their intracellular detection often 
happens through the recognition of nucleic acids (23, 24).    
It is now well accepted that besides TLRs, pathogenic DNA sensing via Stimulator 
of Interferon Genes (STING) signaling is used by the innate immune system to 
recognize intracellular pathogens and to trigger an IFN immune response. Cytosolic 
dsDNA from intracellular bacteria and viruses is bound by cGAMP synthase (cGAS), 
which catalyzes the synthesis of cyclic GMP-AMP (cGMP2’3’). cGMP or bacterial second 
messengers c-di-AMP and c-di-GMP bind to ER (endoplasmic reticulum) associated 
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STING. This binding causes the translocation of STING to the GA (Golgi Apparatus) and 
the recruitment of TANK-binding kinase 1 (TBK1), which phosphorylates the transcription 
factor IFN regulatory factor 3 (IRF3). STING signaling also induces nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-kB), which together with IRF3 regulate 
transcription of type I IFN genes (25). As mentioned before, type I IFN is a pro-
inflammatory cytokine that is crucial in the development of effector and memory CD8 T 
cells (26). However, unexpectedly, the impact of STING signaling on T cells does not 
seem to be related to IFNa/b (27). Indeed, increasing experimental evidence supports an 
IFNb independent role of STING signaling on other processes such as cross-
presentation, autophagy and a T cell intrinsic role in T cell death (28). In addition, while 
STING signaling in antigen presenting cells and other innate cells has been extensively 
studied, less is known about the impact of the strength of STING signaling in the context 
of infection and cancer with regards to the differentiation of effector and memory CD8 T 
cells.  
Given the therapeutic interest of using STING signal agonists as adjuvants in the 
treatment of infection and cancer (29), we decided to evaluate the impact of STING 
signaling levels in the differentiation of CD8 T cells. Previous studies have shown that an 
absence or an increase in STING signaling has surprisingly opposite effects on CD8 T 
cell protection against Listeria monocytogenes rechallenge. High levels of STING 
signaling appeared to decrease T cell based protective immunity, whereas an absence 
of STING signaling improved protection (27). These studies, however, did not fully 
determine the T cell extrinsic and intrinsic roles of STING signaling in T cell function. Nor 
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did they provide molecular mechanistic insight into how the level of STING signals could 
regulate CD8 T cell differentiation in the context of infection. 
In this Masters Thesis project, we have delved into this question. Using cyclic-di-
AMP hypersecreting Listeria monocytogenes strains and STING deficient mouse models, 
we have found that an excess of extrinsic STING signals induces a loss in the generation 
of memory CD8 T cells. Failure to generate memory CD8 T cells was not due to defects 
in the generation of memory or effector precursors, memory programming, or memory 
maintenance. Strikingly, high levels of T cell extrinsic STING signaling increased Bim- 
mediated apoptosis of antigen specific T cells when transitioning to memory.  This was in 
part mediated by tryptophan metabolism. Inhibition of the enzyme IDO, decreased the 
high levels of Bim in T cells and reverted the defect in memory development caused by 
high levels of STING signaling.  
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RESULTS 
T cell responding to antigen in the presence of enhanced STING signaling expand 
but fail to become memory.  
STING is a danger-associated molecular pattern (DAMP)-sensing protein that 
activates the transcription of immune-stimulating genes, including important inflammatory 
molecules such as type I IFNs.  These inflammatory cytokines along with IL-12 provide a 
third signal to activate naïve T cells, emphasizing its role for generating optimal T cell 
responses. Contrary to this, mice lacking the cGAS-STING signaling pathway exhibit 
enhanced immunity against Listeria monocytogenes (27). Thus, we sought to understand 
how STING-mediated inflammation shapes T cell protective immunity.  
We decided to test this in a Listeriosis model of infection, where CD8 T cells are 
crucial for pathogenic clearance and protection (27) We used a recombinant L. 
monocytogenes (LM) that expresses high levels of the STING agonist (30) and mice 
that are STING deficient (Goldenticket) (30, 31). In addition to bacteria being able to 
produce STING agonist cyclic dinucleotides (CDNs), cGAS can generate these second 
messengers in response to double stranded DNA, which bind to and activate STING 
(32). 
C57Bl/6 or STING deficient host mice were first adoptively transferred with 
congenic OT-1 naïve T cells (STING sufficient). Then, mice were infected with an 
attenuated yet immunogenic strain of L. monocytogenes that lacks the actA and inlB 
genes and expresses ovalbumin epitope (SIINFEKL) recognized by the OT-1 T cell 
receptor in the context of MHC Kb (ActA- LM-OVA or WT) or a mutant strain tetR:Tn917 
(tetRActA-LM-OVA or STINGhi) that secretes 20-fold more c-di-AMP than non-attenuated 
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L. monocytogenes (31). In the presence or in the absence of T cell extrinsic STING 
signaling, donor OT-1 T cell responses gave rise to stable T cell memory pools in blood 
(Figure 1A and 1B), indicating that STING deficiency does not alter CD8 T cell memory. 
However, in STINGhi conditions, while OT-1 CD8 T cells expanded, they failed to generate 
a memory pool following the contraction phase (Figure 1A and 1B). The frequency of OVA 
specific T cells responding in STINGhi conditions was dramatically low in blood, lymph 
nodes (LN), and spleen (Figure 1C and D). This phenotype was restricted/constrained to 
antigen specific T cells as the frequency of endogenous CD8 T cells among all conditions 
were similar (Suppl. Figure 2). Collectively, these data show that high levels of STING 
signaling impair the generation of antigen specific CD8 memory T cells.   
 
In the presence of enhanced STING signals, T cells retain functional memory 
programing.  
To understand why enhanced STING signaling impairs memory formation we 
investigated memory programing by examining the expression of Eomes, Bcl-6, and TCF-
1. These factors are transcriptional regulators that progressively accumulate in order to 
prevent terminal differentiation and/ or help maintain memory properties (6, 20). T cells 
that overexpress these memory associated factors generate increased numbers of 
memory cells, and in particular, of the central memory phenotype (20, 33, 34). Thus, 
we tested whether alterations in the expression of these transcription factors could 
contribute to the failure to generate memory T cells in the presence of high levels of 
STING signaling. We found that donor OT-1 T cells at peak and contraction expressed 
similar levels of Bcl-6, Eomes, and TCF-1 (Figure 2A and 2B) regardless of the levels of 
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STING signals (LM-OVA versus LM-OVA STINGhi) . In preliminary data, we did not find 
differences in effector-associated transcription factors T-bet and Blimp-1 that would 
indicate a skewing into effector versus memory differentiation (data not shown). 
Interestingly, the inability to transduce STING signals in STING KO hosts did not alter 
either the expression of Bcl-6, Eomes, and TCF-1. All together, these data suggest that 
STING signaling does not have an impact in memory programming.   
 
CD8 T cells that were primed under supra STING signaling induce high levels of 
the pro-apoptotic factor Bim. 
The previous results indicated the loss of CD8 T cells transitioning to memory, in 
the presence of high levels of STING agonists, was due to mechanisms other than 
memory programming. During the contraction phase of the immune response, 95-99% of 
T cells die by apoptosis leaving behind T cells that survive to form the memory pool. T 
cell death in this case occurs through the intrinsic apoptotic pathway and it is regulated 
by a tight balance in the expression of anti-apoptotic and pro apoptotic factors of the BH3 
family (35, 36). 
Therefore, we next investigated whether induced cell death or lack of cytokine 
survival signals were involved in the STINGhi phenotype (Figure 3). Bim is critical in 
promoting T cell death during the contraction phase of the immune response (16, 37). 
Indeed, CD8 effector cells that lack the pro-apoptotic molecule Bim are almost completely 
spared during contraction (16, 18). We observed that the expression of anti-apoptotic 
molecules Bcl-2 and Bcl-xL in OT-1 donors was similar regardless of the levels of STING 
signaling. However, Bim expression was dramatically upregulated starting at the peak 
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and on into memory. This concurrently happened only when STING signaling levels were 
high (Figure 3A-C).   
Then, we evaluated whether Bim expression was different between terminal 
effector T cells and memory precursors. The primary goal of a T cell response is to 
simultaneously generate an expendable pool of KLRG-1hi CD127lo SLECs to combat 
the present infection and a pool of long-lived KLRG-1lo CD127hi MPECs to combat 
future infections. These T cell populations can be detected in the immune response as 
early as the peak of the response and into memory depending on the infection (16, 18, 
38). After an acute infection has resolved, memory CD8+ T cells are maintained in an 
antigen-independent but cytokine-dependent manner mainly through the actions of the 
homeostatic cytokines IL-7 and IL-15, which promote memory CD8+ T cell survival and 
self-renewal (39). We observed that at contraction, the frequency of donor OT-1 SLECs 
and MPECs expressing low and high levels of the receptor for IL-7 (CD127) 
respectively, remained similar among all conditions (Figure 3D). Furthermore, Bim 
expression levels were not different between MPECS and SLECS (Figure 3E). 
Collectively, these data indicate that CD8 T cell memory loss in STINGhi conditions is 
not due to a defect in the generation or survival of memory precursors. 
Overall, these results indicate that in the context of L. monocytogenes infection, 
enhanced STING levels induce T cell death by promoting the upregulation of the pro-
apoptotic factor Bim. 
 
Inhibition of IDO reverts the induction of T cell death observed under high levels of 
STING signaling.  
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STING signaling has been shown to upregulate the IDO pathway, which causes 
oxidation of the essential amino acid tryptophan. Depletion of tryptophan impairs cytotoxic 
T cells to survival (40, 41). Thus, we hypothesized that an imbalance in IDO expression 
and tryptophan catabolism could account for the increase in T cell death in STINGhi 
conditions. To test this possibility, we repeated experiments in the presence or absence 
of the IDO enzymatic inhibitor 1-methyl-D-tryptophan (1-MT). IDO inhibition restored the 
generation of memory T cells in STINGhi conditions to control levels. (Figure 4A and 4B). 
Importantly, the recovery of CD8 T cell memory correlated with a decrease in Bim levels 
when IDO activity was inhibited. Bcl-2 levels were not affected by IDO inhibition. However, 
Bcl-xL levels were significantly higher at memory for CD8 T cells that were exposed to 
high levels of STING signal in the absence of IDO activity (Figure 4C).  
We also evaluated whether IDO inhibition would induce a change in the expression 
of the receptors for IL-7 and IL-15 which are key for memory CD8 survival. We found that 
treatment with 1-MT did not change the levels of IL-15R on OT-1 donors (Figure 4D). 
Similarly, the frequency of OT-1 MPECs and SLECs remained unaltered in the presence 
of the inhibitor (Figure 4E).  
In sum, these results show that inhibition of IDO allows CD8 T cells to overcome 
Bim induced cell death, observed in over-active STING signaling conditions, and rescue 
memory development.  
Note: Data and analysis obtained to generate Figure 1 and Supplemental Figure 
1 was performed by Rebecca Newth. Supplemental Figure 2 was generated by Karin 
Knudson and Vikas Saxena. Data analysis was carried out by Rebecca Newth. For Figure 
2 and 3, collectively the data was generated by Karin Knudson, Vikas Saxena and 
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Rebecca Newth. Data analysis was performed by Rebecca Newth. The data for Figure 4, 
was generated by Curtis Pritzl and Rebecca Newth. Data analysis was performed by 
Rebecca Newth. Supplemental Figure 3 data was generated by Karin Knudson and Vikas 
Saxena. Data analysis was performed by Emma Teixeiro. 
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DISCUSSION 
 
Memory CD8+ T cells are critical for long-term protection against intracellular 
pathogens and tumors. STING signals enable the transcription of pro-inflammatory 
molecules, such as type I IFNs, in response to nucleic acids from pathogens or self (42-
44). Although the STING signaling pathway is best characterized for generating antiviral 
responses, recent evidence indicates STING signaling is involved in regulating IFN-
independent cellular responses in innate immune cells (45-48). However, it’s role in T 
cells is still poorly understood. Our collaborators published that enhanced STING 
signaling leads to a decrease in T cell protective immunity in a mechanism independent 
of direct IFN signaling on T cells (27). Our data indicates that CD8 T cells expand and 
clear infection but subsequently vanish without differentiating into memory (Figure 1). This 
is not due to impairments in memory programming (Figure 2), rather, CD8 T cell death is 
induced due to high levels of the apoptotic molecule Bim (Figure 3). Our data also suggest 
that T cell death via STING signaling could be attributed to its ability to modulate 
tryptophan metabolism. STING signaling can upregulate the enzyme IDO to catalyze the 
oxidation of tryptophan, a necessary amino acid for T cell survival (41). Indeed, IDO 
inhibition is able to return Bim expression to wildtype levels and restore the generation of 
memory T cells. (Figure 4). Collectively, our data emphasizes a role for tryptophan 
metabolism in the generation of memory CD8 T cells and suggests enhancing STING 
signaling might not be beneficial in all T cell responses.  
A small fraction of the CD8 T cell effector population that responds to an infection 
progresses through the contraction phase to the memory stage. In STINGhi conditions, 
we found CD8 T cells vanish after the peak of infection and memory is not generated 
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(Figure 1). This suggested an issue with regulating contraction, by possibly a defect in 
survival, memory differentiation, or not being able to properly avoid Bim-driven death. 
There are two main hypotheses to explain the mechanisms that control the 
extent of contraction. The first hypothesis suggests that cytokine deprivation, caused by 
having a large population of effector cells, are competing for limited resources (15, 49). 
This suggests that the extent of contraction is actively regulated during contraction by 
the environment. The second hypothesis is based on the observation that the IL-
7Rhi KLRG-1lo MPEC subset, present at the peak of expansion, preferentially survives 
contraction, whereas the IL-7Rlo KLRG-1hi SLEC subset, is more prone to cell death (50, 
51). This predicts the fate of the cell is determined before the contraction phase. 
Evidence suggests the two hypotheses are not mutually exclusive. Known transcription 
factors orchestrate various signals experienced during the effector phase to polarize 
effector terminal differentiation (that results in cell death) or memory formation. Some 
transcription factors are required for both effector and memory T cells, however, their 
differential expression as they progress into the immune response skew T cells towards 
memory or death (52). In addition, there are other transcription factors that singularly 
seem to be required for each one of these fates (Blimp-1, Id3, Runx3) (6, 51, 53). 
Inflammatory cytokines, such as IL-2, IL-12, IFN-γ, and type I IFNs, signal 
through STATs, to direct effector CD8 T cell proliferation and differentiation by inducing 
T-bet and Blimp-1 expression, and downregulating Bcl-6, Eomes, TCF-1, and IL-7R 
expression (52). An increase in type I IFNs in the STINGhi condition could theoretically 
push effectors to the SLEC population fated towards death. However, we found the cell 
death seen in OT-1 T cells is not specific to the SLEC population and the percentage of 
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CD127lo OT-1 T cells does not significantly increase during contraction (Figure 2). 
Conversely, induced cell death of the MPEC population was not seen due to a lack of 
pro-survival IL-7 expression because the percentage of CD127hi cells were not 
significantly decreased (Figure 2). Additionally, we do not see an increase in the 
expression of T-bet (not shown), or downregulation of Bcl-6, Eomes, or TCF-1 
expression (Figure 2). This strongly suggests that alterations in the expression profile of 
these transcription factors did not drive differentiation away from or towards SLECs.  
The interplay of anti-apoptotic molecules and apoptotic molecules is a finely 
orchestrated system. Immune cell survival is controlled by the quantitative participation 
of multiple anti-apoptotic proteins. Bcl-xL and Bcl-2 impair intrinsic apoptosis by 
maintaining mitochondrial integrity. As the ratio of anti-apoptotic proteins, such as Bcl-2 
and Bcl-xL, exceeds that of pro-apoptotic molecules, like Bim, BH3 proteins are 
sequestered and cell death is not initiated (36, 39). Bim specifically is critical for 
activated T cell death, and the cells that survive apoptosis to become memory cells are 
thought to avoid Bim-driven death by the aforementioned mechanisms. The balance of 
Bcl-2 to Bim specifically is important to T cell survival (54). In unstimulated T cells, Bim 
is complexed to Bcl-2 (55) and the downregulation of Bcl-2 that occurs during T cell 
activation may result in increased amounts of free Bim. If cell death was to be induced, 
Bcl-2 and other anti-apoptotic molecules would be downregulated or remain constant. If 
the levels remain constant, this might mean other BH3 proteins, such as Bax and/or 
Bak, might be binding to Bcl-2 in place of Bim. In this scenario, these proteins can free 
Bim from sequestration by competitively binding to Bcl-2 or other anti-apoptotic proteins. 
We found that Bcl-2 and Bcl-xL levels remained constant at contraction, suggesting that 
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the cell did not compensate for the increased levels of Bim, ultimately leading to cell 
death (Figure 3). Future studies should also explore the levels of the pro-apoptotic 
protein Puma. This protein is considered the key mediator of p53-induced apoptosis, but 
can additionally cooperate with Bim to mediate apoptosis in activated T lymphocytes 
during the contraction phase of an immune response (56).    
There are three possible scenarios to take into consideration when interpreting 
how STING signaling might be upregulating Bim induced cell death in CD8 T cells: 1) 
the impact of the inflammatory environment on T cell memory loss, 2) the environment 
created by STING signaling in host APC cells, and 3) STING signaling in responding 
antigen specific T cells transitioning to memory.  
Activation of innate sensors by L. monocytogenes infection leads to extrinsic 
signals that instruct T cells for cell mediated immunity. STING activation in conventional 
DCs leads to the upregulation of co-stimulatory molecules and cell maturation (57). 
STING activates IKK and TBK1 which can then activate NF-κB and IRF3 to induce type 
I IFNs and pro-inflammatory cytokine production (32, 58). The presence of type I IFNs 
has been reported to induce pro-apoptotic activity in T lymphocytes and suggest the 
lack of inflammation is an ideal environment for the generation of memory T cells (59-
63). This begs the question of whether too much STING signaling is producing an 
inhospitable inflammatory environment to the detriment of CD8 T cells (scenario 1).  
IFN-abR deficient mice immunized with attenuated L. monocytogenes that 
express excessive CDNs or immunized in combination with CDNs have reduced 
bacterial burden when challenged with WT L. monocytogenes (27). In this condition 
both innate cells and responding T cells are STING sufficient, but not influenced by 
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type I IFNs. However, IFN-abR deficient CD8 T cells (STING sufficient) adoptively 
transferred into IFN-abR deficient mice (STING sufficient) rescues CD8 T cell 
expansion to a level similar to STING deficient mice. This suggests the induction of T 
cell death that has been reported in response to high levels of STING is independent of 
type I IFNs (27, 64). To confirm this even further when IFN-abR deficient CD8 T cells 
were adoptively transferred into B6 mice and infected in combination with CDNs, T cell 
survival was not recovered. This more specifically indicates that T cell death is not 
caused by a direct effect of Type I IFN on CD8 T cells. 
Then, how can we explain the increased induction of T cell death upon infection 
in our model? Is it dependent on STING expression in innate cells or in T cells or both? 
Clearly when both T cells and infected cells lack STING expression (STING KO hosts in 
Archer et al.) or when only innate cells or infected cells are deficient in STING signals 
(Figure 1), T cell memory generation is not impaired. Additionally, in Archer et al, 
immunization with LLO deficient L. monocytogenes in combination with CDNs (STING 
signaling is provided to other cells but not infected cells in the host) still led to a defect in 
T cell survival and memory generation. Thus, is it possible that what causes T cell death 
is dependent on the expression of STING on T cells? 
Could even STING signaling in our model be directly upregulated in responding 
CD8 T cells? It has been previously reported that the supernatant of macrophages 
previously infected with L. monocytogenes promote T cell apoptosis. Apoptosis was 
caused by the delivery of bacterial DNA that had been packed in extracellular vesicles 
(EV) (65), in a process that was dependent on STING-TBK-1 activity. Curiously, the 
induced T cell death that we observed in our model of L. monocytogenes disappeared 
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when host innate cells lacked STING expression (Figure 1). This is consistent with the 
idea that STING expression in APCs or infected cells would be necessary to transfer 
molecules in the cGAS-STING pathway to responding T cells. Therefore, it is possible 
that under STINGhi conditions, bacterial DNA, CDNs, or even STING in the cytoplasm 
could be sorted into EV and delivered to the donor OT-1 T cells leading to stimulation of 
cGAS-STING pathway that under normal infections remains low. This is an interesting 
idea that will require further investigation. An alternative but complementary idea would 
be the transfer of the signaling intermediate CDNs to other immune cells via gap 
junctions. This has been reported in viral infections and in cancer (66, 67).  
If this phenomenon is occurring, the timing would be an interesting area of 
inquiry. The activation of T cells occurs in several phases (68). Upon detection of the 
presence of cognate antigen (phase 1), the motility of T cells decreases slightly, yet the 
duration of interactions with DCs remains on the order of minutes. After several hours 
(phase 2), most T cells are then organized in clusters around DCs, and have long-lived 
interactions with APCs. Approximately one day after initial T cell transfer, the 
lymphocytes regain their motility and start proliferating (phase 3). However, DC-T cell 
interactions are not contained to secondary lymphoid organs, significant numbers of 
DCs do remain in infected and/or inflamed tissue. 
Could STING signaling in T cells be determining CD8 T cell contraction before 
(phase 1 or 2 of T cell activation) or during the onset of contraction (after phase 3)? The 
former would suggest a direct transfer of cGAS, CDN or STING during priming, 
potentially at the immunological synapse, while the other suggests a paracrine type of 
transfer. One would predict based on our infection model the former scenario because 
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our model is systemic, without tissue specific inflammation to recruit DC for late DC-T 
cell interactions. This is inferred because at memory the majority of donor OT-1 T cells 
are found in the LN and spleen (Figure1) vs the kidney and liver (data not shown). 
STING activation in T cells, either through uptake of an agonist or gain of 
function mutation, are capable of activating cellular stress and triggering T cell specific 
death pathways (69, 70). These studies emphasize how T cells can become 
hyperresponsive to STING signaling after TCR stimulation. This phenomenon was seen 
with concurrent TCR stimulation. The two signals have been shown to synergize to 
induce ER stress, thus tipping the balance toward committing cell death. In our 
infectious model we also found that the induced cell death (through Bim) was specific to 
antigen experienced CD8 T cells (Suppl. Figure 2).  
STING activation leads to type I IFN production and increased expression of IFN 
stimulated genes as previously mentioned. Studies of STING primarily focus on its role 
of inducing an IFN response in macrophages and dendritic cells. IFN-a and IFN-b 
provide crucial protection from many viral and bacterial infections, and synthetic small 
molecule STING agonists have been used as potent adjuvants to induce responses 
against specific model antigens and tumor antigens. Despite growing recognition of 
STING and its biological importance, the mechanism(s) by which it functions to regulate 
IDO and T cell responses remains unclear.  
Elevated tryptophan catabolism can suppress effector T cells and shift the 
balance towards tolerance by activating and stabilizing regulatory T (Treg) cell functions. 
It has been reported that IDO is critical to support the formation and activity of Treg cells. 
IDO competent DCs can enhance Treg cell differentiation from naïve precursors and 
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increase suppressor activity by stimulating mature quiescent Treg cells. Uptake of 
apoptotic cells also polarizes DCs to a tolerogenic state, resulting in the promotion of T 
cell anergy, death, and induction of Treg cells (47). These cells and IDO-competent DCs 
are thought to cooperate by CTLA-4 expression and TGF-b, IL-35 and IL-10 
production to regulate immune suppression (48, 71-74). Furthermore, Tregs are 
important during the contraction phase to regulate CD8 memory development by 
insulating T cells from inflammatory signals (75). However, preliminary data suggests 
there is not a difference in the percentage of Treg cells with IDO inhibitor 1-MT 
treatment, indicating that Treg cells are not likely involved in the defect of CD8 T cells 
memory generation observed when STING signaling is enhanced (Suppl. Figure 1). 
Other studies provide evidence of IDO expressing DCs activating the GCN2 
stress response kinase in responding T cells (76). This led to studies exploring the 
conditions created by IDO that might mediate downstream T cell responses and 
identifying pathways in T cells responding to those conditions (scenario 2). The work of 
Mellor and collegues first proposed the idea that IDO might mediate 
immunosuppression based on the sensitivity of T cells to tryptophan deprivation (77). 
IDO is a rate-limiting enzyme that catalyzes the degradation of tryptophan into various 
metabolites, which can subsequently inhibit T cell proliferation by impairing cell cycle 
machinery and initiating apoptosis (47, 74, 78, 79). The IDO protein is encoded by a 
tightly regulated gene that is responsive to inflammatory mediators. IDO production in 
APCs is usually triggered by IFNs and TGF-b present at the site of infection (80). DCs 
along with MDSC catabolizing tryptophan are known cell types to mediate a tolerogenic 
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response in the tumor microenvironment (80). Altogether these studies support Mellor’s 
original concept, where IDO activity could lead to immunosuppression.   
If Treg cells are not involved, it simply leaves tryptophan metabolism. Amino 
acid uptake is a critical switch for the metabolic reprograming that allows activated T 
cells to mediate an adaptive immune response. After stimulation, T cells rapidly 
upregulate amino acid transporters to sustain T cell responses (81-83). 
Mature DCs that express functional IDO enzyme activity can be potent 
suppressors of T-cell responses in vivo. In a transplantation model, it has been shown 
that memory CD8 T cells are regulated by IDO-mediated tryptophan catabolism (40). 
When IDO activity is suppressed, it has been reported to promote memory formation 
(40, 84). In an influenza model, IDO inhibition resulted in not just an increase in the 
number of memory T cells, but was also characterized by increased expression of IFN-g 
by CD4 and CD8 T cells. We found that IDO inhibition with 1-MT treatment was 
sufficient to prevent the induction of Bim and restore memory in STINGhi conditions 
(Figure 4). Collectively, this supports the idea that in STINGhi conditions, IDO might 
mediate immune suppression in activated T cells based on the sensitivity of T cells to 
tryptophan deprivation (scenario 2). 
The cell death inducing capabilities of STING signaling is not a general response 
to activation of STING, but instead has been reported to be specific to T cells (85). 
Thus, humans encoding constitutively active STING mutations have anti-proliferative 
CD4 T cell activity and reduced numbers of memory CD4 and CD8 T cells (86). Recent 
evidence suggests activation of the STING pathway by STING agonists in dendritic cells 
and macrophages fail to induce expression of pro-apoptotic transcripts Noxa and Puma, 
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while STING protein is rapidly degraded (85). In a macrophage cell line where STING 
expression levels are maintained by a doxycycline-inducible construct of STING, 
stimulation with a STING agonist renders the cell susceptible to STING induced cell 
death (85). T cells stimulated with STING agonists upregulated BH3 proteins Noxa, 
Puma, Bim, and Bad causing their apoptosis (85). Furthermore, several reports using 
mouse models that mimic the mutations that make STING constitutive active in humans, 
have demonstrated the existence of a novel domain in the STING protein that induces T 
cell apoptosis independent of IFNs (70, 86). No study before, however, has evaluated 
the effects of high levels of STING agonists upon infection. T cell death due to an 
upregulation of pro-apoptotic molecules is consistent with the results of our in vivo 
infectious model and could potentially be occurring concurrently with the 
immunosuppressive functions of APCs with enhanced STING signaling. Altogether, this 
suggests the possibility of intrinsic STING signaling in the cytoplasm of responding T 
cells  
The role of IDO in converting T cell responses into tolerogenic verses reactive 
might also depend on TCR signal strength (80, 87). This poses the question of whether 
enhanced STING signaling has different impacts on T memory development depending 
on the strength of the antigenic signal. To address this question, we used L. 
monocytogenes that expresses a low affinity ligand Q4H7 with normal c-di-AMP 
production (ActA- LM-Q4H7 or Q4H7) or excessive c-di-AMP production (tetRActA-LM-
Q4H7 or STINGHi-Q4H7). We have found that enhanced STING signaling severely 
impaired the generation of memory T cells in response to the high affinity antigen OVA, 
which is able to stimulate strong TCR signaling (Suppl. Figure 3). However, and 
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contrary to expectation, increased STING signaling improved T cell protective immunity 
against low affinity antigens at the level of self or tumor antigens (Suppl. Figure 3). This 
can be seen upon secondary exposure with high affinity antigen.  
Our preliminary data suggests low affinity TCR ligands induce functional memory 
CD8 T cells that respond better upon rechallenge. This means that the mechanisms that 
drive the generation of memory T cells change depending on the strength of the antigen 
and has important implications for the design of vaccines against pathogens (strong 
antigens) and tumors (weak antigens). Enhanced STING signaling would be detrimental 
to CD8 T cell memory in combination with high affinity TCR ligands (strong antigens) 
but beneficial in combination with low affinity TCR ligands (weak antigens). CD8 T cells 
primed with high affinity antigens do not respond as robustly upon secondary exposure 
possibly because “too much” stimulation would lead to death. On the other hand, weak 
TCR signal strength would provide enough stimulation to maintain a repertoire capable 
of protecting against bacterial escape variants or tumor neoantigens exposure. 
In summary, we found a new way to control memory T cell development during 
acute infection through the regulation of IDO metabolism. We provide evidence to show 
how tryptophan catabolism is one mechanism by which CD8 T cells are able to sense 
and respond to conditions created by STING signaling. IDO upregulation might be a 
mechanism of peripheral tolerance to prevent the development of an auto-reactive 
memory CD8 population. IDO can be envisioned to operate within innate immune cells 
responding to an inflammatory environment created by STING, for the purpose of 
spreading tolerance and contributing to homeostasis. The concept that tolerance can be 
spread and amplified by the action of few crucial molecules is now becoming 
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established. For future studies is important to understand the relationship between IDO 
inhibition and its impact on the memory response, specifically for antigen specific CD8 T 
cells. It would move the field towards potentially implementing IDO inhibitors to improve 
the outcome of vaccination or in combination with other therapies for cancer treatments. 
Our data reveals an important new function of STING signaling in balancing life and 
death decisions of a T cell. 
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FIGURES 
 
Figure 1. Excessive STING signaling impairs the development of memory CD8 T cells 
(A-D) Naïve OT-1 T cells (1 x 104) were transferred into congenic B6 hosts or Goldenticket, STING deficient mice 
(STING KO) and challenged with 1 x 105 colony-forming units (cfu) of ActA- LM-OVA (WT) or tetRActA-LM-OVA 
(STINGhi).   
(A-B) Frequency of donor OT-1 cells at the peak (day 8), contraction (days 12-16), and memory (day 30 
or later) stages of the immune response in blood. Dot plots are representative of 3 independent 
experiments, with n> 3 mice per condition. ActA- LM-OVA (WT) in B6 congenic host, black line; ActA- LM-
OVA in STING deficient host (STING KO), dashed line; tetRActA-LM-OVA in B6 congenic host (STINGhi), 
red line. 
(C) Graph shows frequency of donor OT-1 CD8 T cells at memory in blood. Data are representative of 3 
independent experiments, with n> 3 mice per condition.  
(D) Graph shows frequency of OVA-specific T cells in lymph nodes (LN) and spleen at memory determined by 
flow cytometry on CD8+ CD90,1+ T cells (mean + SD). Graph is representative of 1 independent 
experiment, 3-4 mice per condition. (*p<0.05, **p<0.005, ***p< 0.0005). 
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Figure 2. Increased STING signaling does not impact memory programming.  
(A-B) OT-1 naïve T cells were transferred into congenic hosts and challenged as described in Figure 1. Expression 
of Eomes, Bcl-6, and TCF-1 were determined by flow cytometry on CD8+ CD90,1+ OT-1 donor T cells at the peak 
(day 6) and contraction (day 12) of the immune response.  
(A) Eomes and Bcl-6 histogram and values are representative of 3 independent experiments, n> 3 mice per 
condition.TCF-1 histograms and MFI values are representative of 1 independent experiment, n> 3 mice per 
condition. Isotype, shaded grey; ActA- LM-OVA (WT) in B6 congenic host, black line; ActA- LM-OVA in 
STING deficient host (STING KO), dashed line; tetRActA-LM-OVA in B6 congenic host (STINGhi), red line. 
(B) Values show normalized geometric MFI for Eomes, Bcl-6, and TCF-1 at peak (day 6) and contraction (day 
12). (*p<0.05, **p<0.005, ***p< 0.0005). 
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Figure 3. Increased STING signaling alters the apoptotic to survival balance at contraction. 
(A-B) OT-1 naïve T cells were transferred into congenic hosts and challenged as described in Figure 1. Expression 
of Bcl-2, Bcl-xL, and Bim were determined by flow cytometry on OT-1 CD8+ CD90,1+ donor T cells at the peak (day 
6) and contraction (day 12-16) of the immune response.  
(A) Bcl-2 and Bim histograms and values are representative of 2 independent experiments, n=3-6 mice per 
condition. Bcl-xL histogram and values are representative of 1 independent experiment, n> 3 mice per 
condition. Isotype, shaded grey; ActA- LM-OVA (WT) in B6 congenic host, black line; ActA- LM-OVA in 
STING deficient host (STING KO), dashed line; tetRActA-LM-OVA in B6 congenic host (STINGhi), red line. 
(B) Values show normalized geometric MFI for Bcl-2, Bcl-xL, and Bim at peak (day 6) and contraction (day 12).  
(C) Bim fold induction over mean WT value through the course of the immune response. Values are 
representative of 2 independent experiments, n=3-6 mice per condition. 
(D) Graph shows frequency of donor CD127 positive or CD127 negative OT-1 CD8 T cells at contraction in 
blood. Designation into high or low population was determined by CD127 expression on naïve T cells in non-
infected mice. Data are representative of 2 independent experiments with n=3-6 mice per condition.  
(E) Normalized geometric MFI for Bim through the course of infection in MPECS (solid) and SLECS (checkered) 
populations. MPECS, KLRG-1Lo CD127Hi; SLECS, KLRG-1Hi CD127Lo. Not shown are SLECS at peak and 
contraction because not significantly different. (*p<0.05, **p<0.005, ***p< 0.0005). 
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Figure 4. Inhibition of IDO restores CD8 T cell memory loss  
(A-E) OT-1 naïve T cells were transferred into congenic hosts and challenged as described in Figure 1. Just before 
peak of infection (day 5) recipient mice are treated with an IDO inhibitor (+ 1-MT) or are control non-treated (N.T.). 
(A)  Frequency of donor OT-1 cells at the peak (day 8), contraction (days 12-16), and memory (day 30 or later) 
stages of the immune response in blood. Dot plots are representative of 2 independent experiments, with n> 
3 mice per condition.  
(B)  Frequency of donor OT-1 cells and percentage of memory loss with and without 1-MT treatment at memory 
(day 30 or later). 
(C)  Bcl-2, Bcl-xL, and Bim fold induction over corresponding non-treated (N.T) individual WT values through the 
course of the immune response. Values are representative of 1 independent experiment, n> 3 mice per 
condition.  
(D) CD122 fold induction over corresponding non-treated (N.T) individual WT values through the course of the 
immune response. Values are representative of 1 independent experiment, n> 3 mice per condition.  
(E) Graph shows frequency of donor CD127 positive predicted MPECs or CD127 negative predicted SLECs 
OT-1 CD8 T cells at contraction in blood. Designation into high or low population was determined by CD127 
expression on naïve T cells in non-infected mice. Data are representative of 1 independent experiments with 
n> 3 mice per condition. (*p<0.05, **p<0.005, ***p< 0.0005). 
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SUPPLEMENTAL FIGURES 
 
Suppl. Figure 1.  Inhibition of IDO has no effect on the T regulatory compartment upon Listeria infection. 
(A-C) OT-1 naïve T cells were transferred into congenic hosts and challenged as described in Figure 4. Graphs are 
representative of at least 2 independent experiments with 3-6 mice per condition. 
(A) Frequency of Treg cells at day 8 of the immune response in blood.  
(B) Values show normalized geometric MFI for Foxp3, at day 8 of the immune response in blood.  
(C) Values show normalized geometric MFI for CD25, at day 8 of the immune response in blood (*p<0.05, 
**p<0.005, ***p< 0.0005). 
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Suppl. Figure 2. IDO induced cell death is not seen for endogenous CD8 T cells. 
(A) OT-1 naïve T cells were transferred into congenic hosts and challenged as described in Figure 4. Frequency of 
CD8+ CD90.1- T cells at memory of the immune response in blood. Graphs are representative of 2 independent 
experiments, with 3-6 mice per condition.  
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Suppl. Figure 3. Enhancement of STING signaling impairs the generation of CD8 T cell memory upon strong 
TCR signaling conditions but not upon weak TCR signaling conditions. 
(A-B) OT-1 naïve T cells were transferred into B6 congenic hosts and challenged as described in Figure 1 or with 1 x 
105 colony-forming units (cfu) of ActA- LM-Q4H7 (Q4H7) or tetRActA-LM-Q4H7 (Q4H7-STINGhi). Graphs are 
representative of 3 independent experiment, with n=3 mice per condition. 
(A) Frequency of donor OT-1 cells at memory (day 30 or later) in blood.  
(B) Frequency of primary and secondary memory OT-1 cells after rechallenge with LM-OVA (1x 105) Filled 
conditions are representative of primary memory and empty with border only are secondary memory. Values 
are the fold increase of secondary memory OT-1 frequency.  
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MATERIALS AND METHODS 
Mice 
Mouse strain C57BL/6 and OT-1.PL (Thy1.1+) TCR transgenic mice were bred 
and maintained according to the University of Missouri OAR, ACUC. Goldenticket (Gt) 
mice were generated from an ENU mutagenesis screen and generously provided by D. 
Portnoy (University of California, Berkley). Gt mice contain a single nucleotide mutation 
in STING resulting in the absence of the STING protein (88).  
 
Bacteria 
L. monocytogenes strains were generously provided by D. Portnoy (University of 
California, Berkley). For tetRActA-Lm-OVA (DP-L6015), the tetR::Tn917 transposon (89) 
was transduced into ActA-Lm-OVA (DactADinlB) (DP-L6014). For in vivo infections, L. 
monocytogenes strains were diluted in BHI and grown to an OD600 of 0.1.  
Adoptive Transfer and Infections  
Donor naive (1x104) OT-1 T cells were purified from the spleen of OT-1 Thy1.1+ 
mice and transferred intravenously through the retro-orbital sinus into C57BL/6 mice. OT-
1 T cells were diluted in phosphate buffered saline (PBS) plus 1% fetal calf serum (FCS) 
in a total volume of 200µl/mouse. All infections were performed at least 1 day after 
adoptive transfer of transgenic T cells. Both male and female mice of all ages were 
infected intravenously with 1x105 CFU of Listeria diluted in PBS in a total volume of 
100µl/mouse. Mice were bled consistently through the course of the infection. At 30 days 
post infection or later, mice were sacrificed, and lymph nodes and spleens were collected.		
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Administration of 1-MT 
For administration of IDO inhibitor 1-MT in drinking water, 1-MT (Sigma-Aldrich D-
1MT, catalog no. 452483) was prepared at 2mg/mL (pH 7-7.3). Before being delivered to 
the mice, the water was filter sterilized and supplemented with 1% sucrose to improve 
acceptance by the mice. Mice drank 4–5 mL/day, similar to consumption of water without 
drug. 1-MT was administered in the drinking water for 2-3 weeks, starting at day 5 post 
infection (freshly made 1-MT water was given every 5 days). 
Flow Cytometry and Antibodies 
Anti-CD8a (53–6.7), CD90.1 (OX-7), TCF-1 (S33-966), and Bcl-2 were from BD 
Biosciences. Anti-CD122 (TM-B1) and CD127 (A7R34) were from Biolegend. Anti-Eomes 
(Dan11Mag) and Bcl-6 (Bc1-DWN) were from eBioscience. Anti-Bcl-xL was from 
Southern Biotechnology. Anti-Bim (C34C5) was from Cell Signaling Technology. 
Secondary antibodies were from Invitrogen. Flow cytometry was performed on a Fortessa 
X20 flow cytometer and the data were analyzed with FlowJo FACS Analysis Software 
(Tree Star). For determining induction of Eomes, Bcl-6, TCF-1, Bcl-2, Bcl-xL, and Bim, 
geometric mean fluorescent intensity was normalized to an isotype control. For 
determining induction of Bcl-2, Bcl-xL, Bim, and CD122 after 1-MT treatment, geometric 
mean fluorescent intensity was normalized to a non-treated WT infected mice.  
Intracellular Staining  
Blood cells were treated with ACK lysis buffer (0.15% NH4Cl, 0.001% KHCO3, 
0.0001% EDTA) before staining. Lymphocytes, splenocytes, and blood cells were 
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washed in FACS buffer (1% FCS, 0.02% sodium azide in PBS) and stained for CD8 and 
congenic markers (CD45.1 or CD45.2 or CD90.2 or CD90.1) to identify donor cells. Cells 
were washed in FACS buffer and then fixed and permeabilized using Cytofix/Cytoperm 
kit according to the manufacturer’s instructions (BD Biosciences). Next, cells were stained 
with specific antibodies. Data were analyzed by flow cytometry.  
Statistical Analysis 
For statistical analysis, two-tailed unpaired Student’s t test was applied, unless 
specified, using GraphPad Prism software. Significance was set at P < 0.05. *P ≤ 0.05, 
**P ≤ 0.005, ***P ≤ 0.005, ****P ≤ 0.001. 
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